BRIEF published on 07/18/2025 at 08:05, 1 year 3 months ago Molten Ventures Engages in Share Repurchase Share Repurchase Ordinary Shares Numis Securities Molten Ventures Market Transaction
BRIEF published on 07/18/2025 at 08:05, 1 year 3 months ago Molten Ventures procède au rachat d'actions Rachat D'actions Actions Ordinaires Numis Securities Molten Ventures Transaction Sur Le Marché
PRESS RELEASE published on 07/18/2025 at 08:00, 1 year 3 months ago Transaction in Own Shares Molten Ventures Plc (GROW) announces the purchase of 50,000 Ordinary Shares at prices ranging from 343.00p to 351.00p per share, part of the share repurchase program Molten Ventures Plc Numis Securities Limited LSE GROW Share Repurchase Program
BRIEF published on 07/17/2025 at 08:05, 1 year 3 months ago Molten Ventures Executes Share Repurchase Program Ordinary Shares Share Buyback Financial Conduct Authority Molten Ventures Deutsche Numis
BRIEF published on 07/17/2025 at 08:05, 1 year 3 months ago Molten Ventures lance un programme de rachat d'actions Rachat D'actions Actions Ordinaires Autorité De Conduite Financière Deutsche Numis Entreprises En Fusion
PRESS RELEASE published on 07/17/2025 at 08:00, 1 year 3 months ago Transaction in Own Shares Molten Ventures Plc (LSE: GROW) announces purchase of 40,000 Ordinary Shares at weighted average price of 347.1185p each. Share repurchase program on 16/07/2025 Share Repurchase Ordinary Shares Molten Ventures Plc Numis Securities LSE: GROW
BRIEF published on 07/16/2025 at 08:05, 1 year 3 months ago Molten Ventures Executes Share Repurchase Program Share Repurchase Ordinary Shares Financial Conduct Authority Molten Ventures Deutsche Numis
BRIEF published on 07/16/2025 at 08:05, 1 year 3 months ago Molten Ventures lance un programme de rachat d'actions Rachat D'actions Actions Ordinaires Autorité De Conduite Financière Deutsche Numis Entreprises En Fusion
PRESS RELEASE published on 07/16/2025 at 08:00, 1 year 3 months ago Transaction in Own Shares Molten Ventures plc (LSE: GROW) announces share repurchase program update. Numis Securities purchased 70,000 Ordinary Shares at prices between 341.20p and 356.60p Share Repurchase Ordinary Shares Molten Ventures Plc GROW Numis Securities
BRIEF published on 07/15/2025 at 08:05, 1 year 3 months ago Molten Ventures Executes Share Buyback Voting Rights Share Buyback Numis Securities Molten Ventures Stock Transactions
Published on 11/10/2026 at 14:31, 45 minutes ago First Breach Plans to Integrate Onboard AI Computing into CQS and LRS Drone Platforms
Published on 11/10/2026 at 14:30, 46 minutes ago Stabilis Solutions Announces Three-Year Take-Or-Pay LNG Supply Agreement with Existing Aerospace Customer
Published on 11/10/2026 at 14:00, 1 hour 16 minutes ago Horizon Aircraft Completes Preliminary Design Review of Cavorite X7 Hybrid eVTOL
Published on 11/10/2026 at 15:05, 11 minutes ago TEADIT® to break ground on Significant Facility Expansion
Published on 11/10/2026 at 15:05, 11 minutes ago JOHNNIE WALKER AND SABRINA CARPENTER SHARE HER 'KEEP WALKING' STORY IN NEW FILM DIRECTED BY DAMIEN CHAZELLE
Published on 11/10/2026 at 14:55, 21 minutes ago Geely Farizon Launches 2027 Model Year SV in Germany, Bringing Integrated Passenger and Commercial Vehicle Services to Local Customers
Published on 11/10/2026 at 14:00, 1 hour 16 minutes ago Guillemot Corporation S.A. | Déclaration hebdomadaire des transactions sur actions propres du 2 au 6 novembre 2026
Published on 11/10/2026 at 14:00, 1 hour 16 minutes ago Guillemot Corporation S.A. | Weekly report share buyback from November 2 to November 6, 2026
Published on 11/10/2026 at 11:02, 4 hours 13 minutes ago Déclaration du nombre d'actions composant le capital social et du nombre total de droits de vote au 31 octobre 2026
Published on 11/10/2026 at 11:02, 4 hours 13 minutes ago Statement about the number of shares composing the share capital and the number of voting rights as of October 31, 2026
Published on 11/10/2026 at 07:00, 8 hours 16 minutes ago bioMérieux receives U.S. FDA 510(k) Clearance and IVDR CE marking for VITEK® PRO, its new automated ID/AST instrument to support the fight against antimicrobial resistance
